In support of NTI's work to build an international consensus for the immediate reduction and phased elimination of highly enriched uranium (HEU) from the civil sector, a new paper by Anton Khlopkov and Miles Pomper, with Valeriya Chekina, develops a market-based roadmap for Russia to transition from HEU to LEU in the production of Molybdenum-99 (Mo-99), which is used in 80% of the medical procedures involving isotopes. Such a plan would serve both an important nonproliferation function and contribute to the global security of Mo-99 supply.
The paper's release comes before the 2014 Nuclear Security Summit in the Hague, where a Russian commitment to phase out the use of HEU in producing Mo-99 would be welcomed.
Read the paper.